文献速递甲状腺与颈部外科

C11胆碱PET/CT在原发性甲状旁腺功能亢进常规定位失败后的应用

C11 choline PET/CT succeeds when conventional imaging for primary hyperparathyroidism fails.
PubMed 文献 · Surgery · 2022-10-11

本研究回顾性分析43例常规定位失败的PHPT患者,33例C11胆碱PET/CT阳性,25例手术者中80%术中治愈,灵敏度64%、阳性预测值72%,5例假阳性(淋巴结、正常甲状旁腺、喉返神经瘤)。提示C11胆碱PET/CT可作为复杂再手术患者的定位辅助手段。

要点

  • 常规定位失败的复杂PHPT患者中,C11胆碱PET/CT灵敏度64%、阳性预测值72%。
  • 手术患者中80%实现术中治愈,72%为再手术病例。
  • 假阳性占20%,包括淋巴结、正常甲状旁腺和喉返神经瘤。

核心结论

  • C11胆碱PET/CT对常规定位失败(超声、I-123司他比或4D-CT)和/或既往手术的复杂PHPT患者是有用的甲状旁腺定位辅助手段。
  • 常规纳入C11胆碱PET/CT可能并非必要,但在再手术情况下可辅助术前定位。

研究设计与样本

  • 单中心回顾性研究,纳入2017至2021年因PHPT评估接受颈胸部局限覆盖C11胆碱PET/CT的患者。
  • 共识别43例患者,其中33例C11胆碱PET/CT阳性,该队列在多种标准影像学检查中均未能定位。
  • 25例患者接受手术,其中72%为再手术病例。

主要发现

  • 25例手术患者中20例(80%)实现术中治愈。
  • C11胆碱PET/CT灵敏度64%(95%CI 47%-82%),阳性预测值72%(95%CI 54%-90%)。
  • 5/25(20%)为假阳性C11胆碱PET结果,分别发现为淋巴结、正常甲状旁腺和1例喉返神经瘤。

关键数值与推荐

  • C11胆碱PET/CT灵敏度64%(95%CI 47%-82%),阳性预测值72%(95%CI 54%-90%)。
  • 假阳性率5/25(20%)。
  • 术中治愈率20/25(80%)。

临床怎么用

  • 对于超声、I-123司他比或4D-CT定位失败和/或既往手术的复杂PHPT患者,可考虑C11胆碱PET/CT辅助定位。
  • 在再手术情况下,C11胆碱PET/CT可能有助于术前定位。
  • 常规纳入C11胆碱PET/CT可能并非必要。

局限性

  • 单中心回顾性研究,样本量较小(43例),手术病例仅25例。
  • 存在假阳性结果(20%),需结合其他影像学或术中探查确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Focused parathyroidectomy in primary hyperparathyroidism is possible with accurate preoperative localization. A growing body of data exists regarding the role of radio-labeled C11 choline positron emission tomography/computed tomography. In cases of nonlocalized disease, it may be a useful adjunct to ultrasound, (123)I/(99)Tc-sestamibi (I-123 sestamibi), or 4-dimensional computed tomography imaging. METHODS: Patients who received a neck and chest limited coverage C11 choline positron emission tomography/computed tomography for evaluation of primary hyperparathyroidism from 2017 to 2021 at a single institution were retrospectively reviewed. We assessed the sensitivity, positive predictive value, and false negative rate. We also compared these rates to the standard modalities of ultrasound, I-123 sestamibi, 4-dimensional computed tomography, and examined concordance rates. RESULTS: We identified 43 patients, of whom 33 had a positive C11 choline positron emission tomography/computed tomography finding. This cohort of patients had failed to localize on multiple standard imaging modalities. Twenty-five patients proceeded to surgery, 72% of whom were reoperative cases. Twenty (80%) achieved an intraoperative cure. Analysis showed that C11 choline positron emission tomography/computed tomography achieved a sensitivity of 64% (95% confidence interval 47%-82%) and positive predictive value of 72% (95% confidence interval 54%-90%). There were 5/25 (20%) false positive positron emission tomography C11 choline results found to be lymph nodes, normal parathyroid, and 1 recurrent laryngeal nerve neuroma. CONCLUSION: C11 choline positron emission tomography/computed tomography is a useful adjunct for parathyroid localization in a complex population of patients who have failed standard localization techniques including ultrasound, I-123 sestamibi, or 4-dimensional computed tomography and/or prior operations. Although routine inclusion of C11 choline positron emission tomography/computed tomography imaging may not be necessary, it may aid in preoperative localization in the reoperative setting.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Saha S, Vierkant RA, Johnson GB, et al. C11 choline PET/CT succeeds when conventional imaging for primary hyperparathyroidism fails. Surgery. 2022. PMID: 36229257. doi:10.1016/j.surg.2022.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。